| Recruiting | REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis Diabetic Ketoacidosis | Phase 2 / Phase 3 | 2025-05-01 |
| Recruiting | Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric I Viral Enteric Infection | — | 2024-08-01 |
| Recruiting | Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Th Stroke, Acute, Stroke, Ischemic | — | 2024-03-01 |
| Recruiting | Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTO Ischemic Stroke | — | 2024-03-01 |
| Completed | Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection Acute Respiratory Viral Infection | — | 2023-09-20 |
| Completed | Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza Influenza, Acute Respiratory Infection | Phase 3 | 2023-09-15 |
| Completed | Cytoflavin in the Complex Rehabilitation of Stroke Patients Stroke | Phase 3 | 2023-06-30 |
| Completed | Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cho Cholestasis, Intrahepatic | Phase 2 / Phase 3 | 2023-05-27 |
| Recruiting | Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice Gallstone Disease, Obstructive Jaundice | — | 2022-12-01 |
| Completed | Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Int Ethanol Intoxication | — | 2022-09-15 |
| Completed | Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy Cancer, Drug Induced Liver Injury | — | 2022-05-12 |
| Completed | Cytoflavin in Combination With Reperfusion in Stroke Patients Acute Stroke | — | 2022-04-10 |
| Completed | Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients Metabolic Acidosis | Phase 2 | 2021-06-16 |
| Completed | Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVI COVID-19 | — | 2020-12-01 |
| Completed | Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy Diabetic Neuropathies | Phase 3 | 2020-11-25 |
| Completed | International Trial of Efficacy of Cytoflavin in Head Trauma Head Trauma,Closed | Phase 3 | 2020-11-22 |
| Completed | "Unifuzol®" in Patients With Peripheral Arterial Disease Peripheral Arterial Disease | Phase 2 | 2018-03-16 |
| Completed | Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Majo Cognitive Dysfunction | Phase 3 | 2017-06-02 |
| Completed | Remaxol® in Malignant Mechanical Jaundice Jaundice; Malignant | Phase 3 | 2017-04-03 |
| Completed | Remaxol® in Mechanical Jaundice of Non-malignant Origin Jaundice, Obstructive | Phase 3 | 2017-04-03 |
| Completed | Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors Ischemic Stroke, Post Intensive Care Unit Syndrome | — | 2016-11-11 |
| Completed | Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers Peripheral Vascular Disease | Phase 1 | 2016-07-15 |
| Terminated | Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome Non-alcoholic Fatty Liver Disease | Phase 2 | 2016-05-30 |